Is dual antiplatelet therapy beneficial for post-CABG diabetes patients?
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Routine dual antiplatelet therapy (DAPT) may not be clinically warranted in diabetes patients with multivessel disease undergoing coronary artery bypass grafting (CABG).
Why this matters
- Diabetes is independently associated with increased perioperative and long-term mortality ...